medigraphic.com
ISSN 1025-0255 (Electronic)

2012, Number 3

<< Back Next >>

AMC 2012; 16 (3)

How to evaluate a patient with myotonia

Herrera LOA

Language: Spanish
References: 38
Page: 353-368
PDF size: 148.69 Kb.


ABSTRACT

Introduction: myotonia is a muscle disorder, characterized by a delayed relaxation of a skeletal muscle after a voluntary contraction or by percussion.
Development: the physiopathology in the light of current knowledge regarding genetic defects associated with channelopathies is presented. Positive and differential diagnosis, classification, main clinical forms and treatment are discussed.
Conclusions: despite a growing understanding of the genetic basis of these disorders, clinical features and the electro-diagnostic remain as insuperable allies in positive and differential diagnosis. On myotonia no dystrophica there are some answers, with many more questions both its medical examination and its classification and treatment.


REFERENCES

  1. Meola G, Moxley RT. Myotonic dystrophy type 2 and related myotonic disorders. J eurol. 2004; 251:1173-82.

  2. Machuca-Tzili L, Brook D, Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve. 2005; 32:1-18.

  3. Meola G, Sansone V, Marinou K, Cotelli M, Moxley RT, Thornton CA, et al. Proximal myotonic myopathy: a syndrome with a favourable prognosis? J Neurol Sci. 2002; 193:89-96

  4. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick A, Kress W. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology. 2003; 60:657-64.

  5. Heatwole CR, Moxley RT. The Nondystrophic Myotonias.Neurotherapeutics. 2007; 4:238-51.

  6. Raja Rayan DL, Hanna MG. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol. 2010 Oct; 23(5):466-76.

  7. Lehmann Horn F, Jurkat Rott K, Rudel R. Diagnostics and Therapy of Muscle Channelopathies - Guidelines of the Ulm Muscle Centre. Acta Myol. 2008 December; 27(3):98-113.

  8. Ryan AM, Matthews E, Hanna MG. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias. Curr Opin Neurol. 2007 Oct; 20(5):558-63.

  9. Lehmann-Horn F, Rudel R, Jurkat-Rott K. Nondystrophic myotonias and periodic paralyses. 3rd edition. New York: McGraw-Hill; 2004.

  10. Udd B, Meola G, Krahe R, Thornton C, Ranum LP, Bassez G, et al. ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord. 2006; 16:403-13.

  11. Mankodi A. Myotonic disorders. Neurology India. 2008; 56(3):298-304.

  12. Shapiro B, Ruff R. Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis,and related disorders. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE, editors. Neuromuscular disorders in clinical practice. Boston: Butterworth-Heinemann; 2002.p.987-1020.

  13. Adams R, Victor M. Disorders of muscle characterized by cramp, spam, pain, and localized masses. In: Adams R, Victor M, editors. Principios de Neurología. 6ta Ed. Boston: Mc Graw Hill Interamericana. 2005.p.1276-84.

  14. Coers C, Teleman Toppet N, Durda J. Neurogenic benign fasciculations, pseudomyotonia, and pseudotetany. Arch Neurol.1981;38:282-4.

  15. Isaacs H. Continuous muscle fibre activity in an Indian male with additional evidence of terminal motor fibre abnormality. J Neurol Neurosurg Psychiatry.1967; 30:126-30.

  16. Brooke MH. Disorders of skeletal muscle. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. 3rd ed. Boston: Butterworth-Heinemann; 2003.p.2187-223.

  17. Fischer D, Schroder R. Isaacs' syndrome. Diagnosis and differential diagnosis of neuromyotonia. Nervenarzt. 2004 Jun; 75(6):531-5.

  18. Gonzalez G, Barros G, Russi ME, Nuñez A, Scavone C. Acquired neuromyotonia in childhood: case report and review. Pediatr Neurol. 2008 Jan; 38(1):61-3.

  19. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity (stiff-man syndrome): Report of a case and some observations in 13 other cases. Mayo Clin Proc.1956; 31:421-3.

  20. Raju R, Hampe CS. Immunobiology of stiff-person syndrome. Int Rev Immunol. 2008; 27:79-92.

  21. Piróg KA, Briggs MD. Skeletal Dysplasias Associated with Mild Myopathy A Clinical and Molecular Review. J Biomed Biotechnol. 2010 May; 24(10):11-55.

  22. Kulkarni ML, Rajappan P. Schwartz-Jampel Syndrome. Indian Pediatrics. 2004;2:285.

  23. Voermans NC, Bonnemann CG, Huijing PA. Clinical and molecular overlap between myopathies and inherited connective tissue diseases. NeuromuscularDisorders. 2008; 18(11):843-56.

  24. Harper P. Myotonic dystrophy: a multisystemic disorder. In: Harper P, Van Engelen B, Eymard B, editors. Myotonic dystrophy: present management, future therapy. Oxford: Oxford University Press; 2004.p.3-13.

  25. Lossin C, George AL. Myotonia congenita. Adv Genet. 2008; 63(2):25-55.

  26. Colding Jorgensen E. Phenotypic variability in Myotonia Congenita. Muscle Nerve. 2005; 32(3):19-34.

  27. Cherian A, Neeraj N, Kuruvilla A. Muscle channelopathies and electrophysiological approach. Ann Indian Acad Neurol. 2008 Jan-Mar; 11(1):20-7.

  28. Fournier E, Arzel M, Sternberg D, Vicart S, Laforet P, Eymard B, et al. Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol. 2004; 56:650-61.

  29. Amato AA, Dumitru D. Hereditary myopathies. In: Dumitru D, Amato AA, Zwarts MJ, editors. Electrodiagnostic medicine. 2nd ed. Philadelphia: Hanley and Belfus; 2002.p.1265-1370.

  30. Vicart S, Sternberg D, Fontaine B, Meola G. Human skeletal muscle sodium channelopathies. Neurol Sci. 2005 Oct; 26(4):194-202.

  31. Platt D, Griggs R. Skeletal Muscle Channelopathies: New insights into the periodic paralyses and nondystrophic myotonias. Curr Opin Neurol. 2009 Oct; 22(5):524-31.

  32. Fournier E, Viala K, Gervais H, Sternberg D, Arzel-Hezode M, Laforet P, et al. Cold extends electromyography distinction between ion channel mutations causing myotonia. Ann Neurol. 2006 Sept; 60(3):356-65.

  33. Ricker K, Moxley RT, Heine R, Lehmann-Horn F. Myotonia fluctuans: a third type of muscle sodium channel disease. Arch Neurol. 1994; 51:1095-1102.

  34. Colding Jorgensen E, Duno M, Vissing J. Autosomal dominant monosymptomatic myotonia permanens. Neurology. 2006; 67:153-5.

  35. Kubota T, Kinoshita M, Sasaki R, Aoike F, Takahashi MP, Sakoda S, et al. New mutation of the Na channel in the severe form of potassium-aggravated myotonia. Muscle Nerve. 2009 May; 39(5):666-73.

  36. Ptacek LJ, Tawil R, Griggs RC. Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology. 1994;44:1500-05.

  37. Venance SL, Cannon SC, Fialho D, Fontaine B, Hanna MG, Ptacek LJ, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006 Jan; 129(Pt 1):8-17.

  38. Moxley RT, Tawil R. Channelopathies: myotonic disorders and periodic paralysis. In: Swaiman KF, Ashwal S, Ferriero DM, editors. Pediatric neurology: principles and practice. 4th ed. Philadelphia: Mosby; 2006.p.2085-2109.




2020     |     www.medigraphic.com